Russian Covid-19 Drug Clinically Proven to Work, RDIF CEO Says

The transcript discusses a new antiviral drug developed in Russia, which is one of the first against COVID-19. It highlights the drug's efficacy in reducing virus elimination time and compares it with other treatments. The discussion also covers clinical trials, global collaboration, and the potential inclusion of Russia in the G7. Additionally, the impact of COVID-19 on oil prices and the economy is addressed, emphasizing the need for international cooperation.

How does the text describe the relationship between the drug's effectiveness and the competition with other treatments?

What are the expectations for the third stage clinical trial of the drug?

What are the potential risks associated with the drug as mentioned in the text?